Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats

Journal of Bone and Mineral Research

Volumn 11, Issue 10, 1996, Pages 1508-1517

  Lepola, Vesa T ^a   Kippo, Katriina ^b   Hannuniemi, Ritva ^b   Laurén, Leena ^b   Virtamo, Teija ^b   Österman, Thua ^b   Jalovaara, Pekka ^a   Sellman, Raija ^b   Väänänen, H Kalervo ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Biomedical Research Center   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; OSTEOCALCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN DEFICIENCY; FEMALE; FEMUR NECK; LUMBAR VERTEBRA; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOPENIA; OVARIECTOMY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRABECULAR BONE;

EID: 0029782607     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650111018     Document Type: Article

References (37)

1. Kalu DN 1991 The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-192.
2. Wronski TJ 1992 The ovariectomized rat as an animal model for postmenopausal bone loss. Cells Mater 1 (Suppl 1):69-74.
3. Bagi CM, Mecham M, Weiss J, Miller SC 1993 Comparative morphometric changes in rat cortical bone following ovariectomy and/or immobilization. Bone 14:877-883.
4. 2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. Bone 11:253-266.
5. Wronski TJ, Dann LM, Horner, SL 1989 Time course of vertebral osteopenia in ovariectomized rats. Bone 10:295-301.
6. Mosekilde L, Danielsen CC, Knudsen UB 1993 The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats. Bone 14:1-6.
7. Fleisch H 1991 Bisphosphonates: Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42:919-944.
8. Toolan BC, Shea M, Myers ER, Borchers RE, Seedor JG, Quartuccio H, Rodan G, Hayes WC 1992 Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats. J Bone Miner Res 7:1399-1406.
9. Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA, Hayes WC 1993 Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J Bone Miner Res 8:871-879.
10. Mosekilde Li, Søgaard CH, McOsker JE, Wronski TJ 1994 PTH has more prounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate) - Assessed in sexually mature, ovariectomized rats. Bone 15:401-408.
11. Søgaard CH, Wronski TJ, McOsker JE, Mosekilde Li 1994 The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen and bisphosphonates. Endocrinology 134:650-657.
12. Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D, Quartuccio H, Fioravanti C, Clair J, Brown E, Hayes WC, Rodan GA 1993 The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577-2586.
13. Katsumata T, Nakamura T, Ohnishi T, Sakurama T 1995 Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats. J Bone Miner Res 10:921-925.
14. Rico H, Amo C, Revilla M, Arribas I, Gonzalez-Riola J, Villa LF, Rodriquez-Puyol M 1994 Etidronate versus clodronate in the prevention of postovariectomy bone loss: An experimental study in rats. Clin Exp Rheumatol 12:301-304.
15. Kippo K, Hannuniemi R, Virtamo T, Laurén L, Ikävalko H, Kovanen V, Österman T, Sellman R 1995 The effects of clodronate on increased bone turnover and bone loss due to ovariectomy in rats. Bone 17:533-542.
16. Lepola V, Väänänen K, Jalovaara P 1993 The effect of immobilization on the torsional strength of the rat tibia. Clin Orthop 297:55-61.
17. Peng Z, Tuukkanen J, Zhang H, Jämsä T, Väänänen HK 1994 The mechanical strength of bone in different rat models of experimental osteoporosis. Bone 15:523-532.
18. Crenshaw TD, Peo ER, Lewis AJ, Moser BD 1981 Bone strength as a trait for assessing mineralization in swine: A critical review of techniques involved. J Animal Sci 53:827-835.
19. Schenk RK, Olah AJ, Herrmann W 1984 Preparation of calcified tissues for light microscopy. In: Dickson GR (ed.) Methods of Calcified Tissue Preparation. Elsevier, Amsterdam, The Netherlands, pp. 1-56.
20. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest 72:1396-1409.
21. Donath K 1993 Preparation of histologic sections by the cutting-grinding technique for hard tissue and other material not suitable to be sectioned by routine methods - equipment and methodical performance. Exakt-Kulzer-Publication, Norderstedt, Germany.
22. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610.
23. Black D, Duncan A, Robins SP 1988 Quantitative analysis of the pyridinum crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 169:197-203.
24. Rockoff SD, Sweet E, Bleustein J 1969 The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res 3:163-175.
25. Lotz JC, Gerhart TN, Hayes WC 1991 Mechanical properties of metaphyseal bone in the proximal femur. J Biomechanics 24:317-329.
26. Turner RT, Vandersteenhoven JJ, Bell NB 1987 The effects of ovariectomy and 17B-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2:115-122.
27. Chow JWM, Badve S, Chambers TJ 1993 A comparison of microanatomic basis for coupling between bone formation and bone resorption in man and in the rat. Bone 14:355-360.
28. Lepola VT, Hannuniemi R, Kippo K, Laurén L, Jalovaara P, Väänänen HK 1996 Long-term effects of clodronate on growing rat bone. Bone 18:191-196.
29. Kanis JA, McCloskey EV 1990 The use of clodronate in disorders of calcium and skeletal metabolism. In: Kanis JA (ed.) Calcium Metabolism: Progress in Basic and Clinical Pharmacology. Karger, Basel, Switzerland, pp. 89-136.
30. Hannuniemi R, Laurén L, Puolijoki H 1991 Clodronate: An effective agent for the treatment of increased bone resorption. Drugs 27:375-390.
31. Pentikäinen PJ, Elomaa I, Nurmi A-K, Kärkkäinen S 1989 Pharmacokinetics of clodronate in patients with metastatic breast cancer. Int J Clin Pharmacol Ther Toxicol 27:222-228.
32. Ammann A, Rizzoli R, Müller K, Slosman D, Bonjour J-P 1993 IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats. Am J Physiol 265:E770-E776.
33. Fleisch H, Russell RGG, Francis MD 1969 Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 165:1262-1264.
34. Wronski TJ, Dann LM, Scott S, Crooke LR 1989 Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology 125:810-816.
35. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH 1990 Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. New Engl J Med 322:1265-1271.
36. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson G, Yanover MJ, Wysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B, Chesnut CH 1990 Intermittent cycloical etidronate treatment of postmenopausal osteoporosis. New Engl J Med 323:73-79.
37. Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnut CH 1993 Four-year study of intermittent cyclical etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy. Am J Med 95:557-567.